InsiderPresident & CEO

August J. Troendle Insider Trading Activity

Every SEC Form 4 transaction reported by August J. Troendle, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is August J. Troendle buying or selling?

August J. Troendle reported 10 open-market buys ($154.6M) and 128 sells ($1.5B) across 138 Form 4 filings at 1 company — a net selling position of $1.4B.

Source: SEC EDGAR Form 4

What stands out

  • All 138 of August J. Troendle's Form 4 filings are for one company, Medpace Holdings, Inc. (MEDP).
  • The most recent Form 4 was accepted on Oct 1, 2026 (17 days ago).
  • In the last 12 months: no open-market purchases and 21 sales ($358.5M).
  • The largest open-market sale in the last 12 months was $62.0M of Medpace Holdings, Inc. (MEDP) on Nov 26, 2025. SEC ↗

Key Statistics (as of Oct 1, 2026)

Total Form 4 filings
138
SEC EDGAR
Companies
1
Buys (10)
$154.6M
Sells (128)
$1.5B

Insider sentiment

Net selling

Net insider flow of $1.4B in net selling, filed between Aug 6, 2018 – Oct 1, 2026.

Companies August J. Troendle files for

#CompanyForm 4 filings
1MEDPMedpace Holdings, Inc.138

Recent August J. Troendle transactions

DateTickerRoleTypeSharesValueFiling
Oct 1, 2026MEDPPresident & CEOSale48.7K$30.3MSEC ↗
Sep 29, 2026MEDPPresident & CEOSale2.6K$1.6MSEC ↗
Sep 25, 2026MEDPPresident & CEOSale43.9K$27.4MSEC ↗
Sep 23, 2026MEDPPresident & CEOSale70.9K$44.4MSEC ↗
Sep 21, 2026MEDPPresident & CEOSale10.9K$6.7MSEC ↗
Sep 17, 2026MEDPPresident & CEOSale24.7K$15.4MSEC ↗
Aug 31, 2026MEDPPresident & CEOSale650$403.2KSEC ↗
Aug 27, 2026MEDPPresident & CEOSale4.7K$2.9MSEC ↗
Aug 25, 2026MEDPPresident & CEOSale16.0K$10.0MSEC ↗
Aug 21, 2026MEDPPresident & CEOSale42.8K$26.3MSEC ↗
Aug 14, 2026MEDPPresident & CEOSale11.8K$7.1MSEC ↗
Aug 12, 2026MEDPPresident & CEOSale23.1K$14.0MSEC ↗
Jul 29, 2026MEDPPresident & CEOSale7.2K$4.3MSEC ↗
Dec 4, 2025MEDPCEOSale668$394.6KSEC ↗
Dec 3, 2025MEDPCEOSale28.9K$17.1MSEC ↗
Dec 1, 2025MEDPCEOSale56.5K$34.1MSEC ↗
Nov 26, 2025MEDPCEOSale101.4K$62.0MSEC ↗
Nov 24, 2025MEDPCEOSale28.7K$17.0MSEC ↗
Nov 20, 2025MEDPCEOSale31.1K$18.4MSEC ↗
Nov 18, 2025MEDPCEOSale20.8K$12.4MSEC ↗
Nov 14, 2025MEDPCEOSale10.4K$6.3MSEC ↗
Sep 3, 2025MEDPCEOSale37.4K$17.8MSEC ↗
Aug 28, 2025MEDPCEOSale620$294.5KSEC ↗
Jul 29, 2025MEDPCEOSale48.5K$21.9MSEC ↗
May 29, 2024MEDPCEOSale9.7K$3.8MSEC ↗

Showing the 25 most recent filings of 138. Screen every filing.

August J. Troendle insider trading FAQ

Is August J. Troendle buying or selling?

Across 138 SEC Form 4 filings, August J. Troendle reported 10 open-market purchases totaling $154.6M and 128 sales totaling $1.5B — a net selling position of $1.4B.

Which companies does August J. Troendle file Form 4s for?

August J. Troendle has reported insider transactions at 1 company, most often Medpace Holdings, Inc. (MEDP).

How far back does August J. Troendle's filing history go?

Trabud holds August J. Troendle's SEC Form 4 filings from Aug 6, 2018 – Oct 1, 2026, sourced directly from SEC EDGAR.

Where does Trabud get August J. Troendle's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track August J. Troendle and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener